SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
03-Apr-23 8:47 PM View: | Katzaroff James C CEO Director | Globestar Therapeutics Corp (GSTC) | 03-Apr-23 | Acquisition (other) | 70,422,496 | $0.01 | $500,000.00 | 704% 10.0M to 80.42M | |
28-Feb-20 4:03 PM View: | Atwood Brent 10% Owner | Globestar Therapeutics Corp (GSTC) | 25-Feb-20 | Disposition | 31,675,700 | $0.00 | $35,958.10 | (100%) 31.68M to 0 | |
15-Aug-19 8:54 PM View: | Atwood Brent 10% Owner | Globestar Therapeutics Corp (GSTC) | 14-Aug-19 | Purchase | 2,827,190 | $0.02 | $44,043.80 | 13% 22.39M to 25.22M | |
15-Aug-19 8:54 PM View: | Atwood Brent 10% Owner | Globestar Therapeutics Corp (GSTC) | 13-Aug-19 | Private Purchase | 9,349,530 | $0.02 | $186,991.00 | 72% 13.04M to 22.39M | |
11-Dec-18 12:53 PM View: | Blankenship Alex K President and CEO Director | Globestar Therapeutics Corp (GSTC) | 06-Dec-18 | Purchase | 3,500,000 | -- | -- | 140% 2.5M to 6.0M | |
29-Aug-19 10:00 PM View: | Blankenship Alex K President and CEO Director | Globestar Therapeutics Corp (GSTC) | 19-Jul-17 | Purchase | 2,000,000 | $2,000.00 | $4,000,000,000.00 | 133% 1.5M to 3.5M | |
08-Jun-17 10:44 AM View: | Blankenship Alex K President and CEO Director | Globestar Therapeutics Corp (GSTC) | 07-Apr-17 | Purchase | 500,000 | -- | -- | 100% 0 to 500.0K | |
29-Aug-19 10:00 PM View: | Blankenship Alex K President and CEO Director | Globestar Therapeutics Corp (GSTC) | 11-Aug-16 | Purchase | 1,000,000 | $1,000.00 | $1,000,000,000.00 | 200% 500.0K to 1.5M |